AFT-16: Phase II Trial of Neoadjuvant and adjuvant Atezolizumab (A) and Chemoradiation (CRT) for Stage III Non-small Cell Lung Cancer (NSCLC)
      Google Scholar   
Citation:
J Clin Oncol vol 39 (no. 15_suppl) 8513
Meeting Instance:
ASCO 2021
Year:
2021
Type:
Abstract
Sub type:
Funding:
AFT
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
4020  
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
Genentech  
Grants:
 
Corr. Author:
 
Authors:
                         
Networks:
CA043, CA249, IL043, LAPS-IL057, LAPS-MA036, LAPS-NC010   
Study
AFT-16
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: